Back to Search Start Over

PEG3mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer

Authors :
Jin Zhang
Min Zhang
Source :
Bioscience Reports
Publication Year :
2020
Publisher :
Portland Press Ltd., 2020.

Abstract

Background: Breast cancer is the second most common malignancy in women and considered as a severe health burden. PEG3 mutations have been observed in several cancers. However, the associations of PEG3 mutation with tumor mutation burden (TMB) and prognosis in breast cancer have not been investigated. Methods: In our study, the somatic mutation data of 986 breast cancer patients from The Cancer Genome Atlas (TCGA) were analyzed. Results: It showed that PEG3 had a relatively high mutation rate (2%). After calculated the TMB in PEG3 mutant and PEG3 wild-type groups, we found the TMB value was significantly higher in PEG3 mutant samples than that in PEG3 wild-type samples (P = 5.6e-07), which was independent of the confounding factors including age, stage, mutations of BRCA1, BRCA2 and POLE (odd ratio, 0.45; 95% CI, 0.20–0.98; P=0.044). Survival analysis revealed that PEG3 mutant samples had inferior survival outcome compared with the PEG3 wild-type samples after adjusted for the confounding factors above (hazard ratio, 0.27; 95% CI: 0.12–0.57; P

Details

ISSN :
15734935 and 01448463
Volume :
40
Database :
OpenAIRE
Journal :
Bioscience Reports
Accession number :
edsair.doi.dedup.....c122c55c812dbe3584c8fe31bfed4620